Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W MacNee

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Annals of the New York Academy of Sciences|December 31, 1991
Validation of markers of lung destructionB Burrows, D V Bates, M G Cosio, et al.
QJM : Monthly Journal of the Association of Physicians|March 11, 2009
Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trialJ K Baillie, A A R Thompson, J B Irving, et al.
The European Respiratory Journal|January 25, 2008
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)J Vestbo, W Anderson, H O Coxson, et al.
Thorax|November 21, 2007
Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular riskN L Mills, J J Miller, A Anand, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 27, 2015
Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot studyR M Mroz, P Lisowski, A Tycinska, et al.
The European Respiratory Journal|September 1, 2001
"Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999I Horváth, W MacNee, F J Kelly, et al.
The European Respiratory Journal|October 2, 2007
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPDS Chappell, L Daly, K Morgan, et al.
The European Respiratory Journal|July 11, 2008
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPDS Chappell, L Daly, K Morgan, et al.
The European Respiratory Journal|February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkersM Cazzola, W MacNee, F J Martinez, et al.
The Pharmacogenomics Journal|October 28, 2015
A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary diseaseM Hardin, M H Cho, M-L McDonald, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Annals of the New York Academy of Sciences|December 31, 1991
Validation of markers of lung destructionB Burrows, D V Bates, M G Cosio, et al.
QJM : Monthly Journal of the Association of Physicians|March 11, 2009
Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trialJ K Baillie, A A R Thompson, J B Irving, et al.
The European Respiratory Journal|January 25, 2008
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)J Vestbo, W Anderson, H O Coxson, et al.
Thorax|November 21, 2007
Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular riskN L Mills, J J Miller, A Anand, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 27, 2015
Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot studyR M Mroz, P Lisowski, A Tycinska, et al.
The European Respiratory Journal|September 1, 2001
"Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999I Horváth, W MacNee, F J Kelly, et al.
The European Respiratory Journal|October 2, 2007
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPDS Chappell, L Daly, K Morgan, et al.
The European Respiratory Journal|July 11, 2008
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPDS Chappell, L Daly, K Morgan, et al.
The European Respiratory Journal|February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkersM Cazzola, W MacNee, F J Martinez, et al.
The Pharmacogenomics Journal|October 28, 2015
A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary diseaseM Hardin, M H Cho, M-L McDonald, et al.
Pageof 19